See every side of every news story
Published loading...Updated

Trump tariff: India’s strict testing rules for chemicals, medical devices hurt US exports, says White House

  • The U.S. Plans to impose reciprocal tariffs on Indian products affecting agriculture, machinery, and pharma, according to experts.
  • The pharmaceutical sector, India's largest export at $12.72 billion, may face a 10.90% tariff differential, raising medicine costs.
  • Leader of the Opposition Rahul Gandhi criticized the government's handling of U.S. Tariffs, stating they would 'devastate our economy,' especially in the pharmaceutical industry.
  • Gandhi also raised concerns about China's encroachment on Indian territory, claiming the government fails to take a firm position on the issue.
Insights by Ground AI
Does this summary seem wrong?

14 Articles

All
Left
2
Center
1
Right
2
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 40% of the sources lean Left, 40% of the sources lean Right
40% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hindu broke the news in India on Wednesday, April 2, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.